Dechun Huang

Prof. Dr. Dechun Huang


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2017 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
TDTao Deng
Tao Deng
YPYanan Peng
Yanan Peng
RZRong Zhang
Rong Zhang
JWJie Wang
Jie Wang
JZJie Zhang
Jie Zhang
DDDawei Deng
Dawei Deng

8 February 2022 in Journal of Controlled Release
Verified
Journal Article
Closed access
HQHongliang Qian
Hongliang Qian
KWKe Wang
Ke Wang
MLMengtong Lv
Mengtong Lv
CZChangshun Zhao
Changshun Zhao
HWHui Wang
Hui Wang
YZYinan Zhong
Yinan Zhong

5 April 2019 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
HQHaishi Qiao
Haishi Qiao
XCXingmei Chen
Xingmei Chen
ECEnping Chen
Enping Chen
JZJunmei Zhang
Junmei Zhang
DHDechun Huang
Dechun Huang
WCWei Chen
Wei Chen
Combining chemotherapy and immunotherapy has been considered as an attractive approach to improve cancer therapy. Here we prepared folated PVA-based nanogels for the simultaneous delivery of docetaxel (DTX) and the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor NLG919 (N9) for enhancing cancer chemo-immunotherapy. FDA-approved poly(vinyl alcohol) (PVA) with good biocompatibility was modified with vinyl ether acrylate (VEA) groups for UV-crosslinking and acidic degradation. Carboxyl groups were introduced via modification with succinic anhydride for improved drug loading and folic acid (FA) ligands were incorporated for tumor targeting. UV-crosslinked folated PVA nanogels were efficiently taken up by tumor cells followed by endo/lysosomal pH-triggered intracellular drug release, which induced significant cytotoxicity towards 4T1 breast cancer cells in vitro. DTX and N9 co-loaded PVA nanogels exhibited a much higher antitumor efficiency in 4T1 mouse breast cancer models in vivo as compared to the free drug controls. The drug-laden nanogels not only directly killed the tumor cells by DTX, but also induced immunogenic cell death (ICD) promoting intratumoral accumulation of cytotoxic T lymphocytes, and further combining with N9 elevated the intratumoral infiltration of CD8+ T cells and NK cells and inhibited the infiltration of MDSCs, downregulating IDO1-mediated immunosuppression.

18 September 2021 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
RBRaut Bholakant
Raut Bholakant
BDBin Dong
Bin Dong
XZXiang Zhou
Xiang Zhou
XHXin Huang
Xin Huang
CZChangshun Zhao
Changshun Zhao
JFJan Feijen
Jan Feijen
Schematic diagram of multi-functional PMs for chemotherapy-based combined cancer therapy: combination of multiple chemotherapy drugs; combinational chemo-gene therapy; combinational chemo-phototherapy; combinational chemo-immunotherapy.

15 November 2016 in Journal of Chemical & Engineering Data
Verified
Journal Article
Closed access
HQHongliang Qian
Hongliang Qian
XGXiaojing Guo
Xiaojing Guo
SFSudong Fan
Sudong Fan
KHKiros Hagos
Kiros Hagos
XLXiaohua Lu
Xiaohua Lu
DHDechun Huang
Dechun Huang

1 October 2021 in Biomaterials
Verified
Journal Article
Closed access
ZLZhihong Liu
Zhihong Liu
YZYinan Zhong
Yinan Zhong
XZXiang Zhou
Xiang Zhou
XHXin Huang
Xin Huang
JZJingjing Zhou
Jingjing Zhou
WCWei Chen
Wei Chen